Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medplus Health Services Limited has disclosed that Optival Health Solutions Private Limited, its subsidiary, received a suspension order for a Drug License from the Assistant Director, Drugs Control Administration, Circle-3 Bangalore, Karnataka. The suspension is for five days affecting one store located at 24th Main, 4th T Block, Jayanagar, Karnataka. The order was received on April 21, 2026. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of Rs 5.39 lakhs due to this suspension.
This is a minor regulatory event affecting only one store for five days with limited financial impact. The suspension is unlikely to have any material effect on the company's overall operations or stock performance given the small revenue exposure.